BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪13.37 B‬CNY
0.45CNY
‪202.47 M‬CNY
‪1.17 B‬CNY
‪196.40 M‬
Beta (1Y)
1.83
Employees (FY)
‪1.16 K‬
Change (1Y)
+27 +2.39%
Revenue / Employee (1Y)
‪143.14 K‬CNY
Net income / Employee (1Y)
‪24.69 K‬CNY

About BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.


CEO
Jian Dong Yuan
Headquarters
Suzhou
Founded
2001
ISIN
CNE100003PR1
FIGI
BBG00NV0D3S3
BrightGene Bio-Medical Technology Co., Ltd. engages in the research & development, and manufacturing of biopharmaceuticals, medicines as well as special generic active pharmaceutical ingredients and finished dosage forms. The company was founded by Yuan Jian Dong on October 26, 2001 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 688166 is 31.90 CNY — it has increased by 1.58% in the past 24 hours. Watch BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stocks are traded under the ticker 688166.
688166 stock has fallen by −9.16% compared to the previous week, the month change is a −1.38% fall, over the last year BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. has showed a −15.34% decrease.
We've gathered analysts' opinions on BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. future price: according to them, 688166 price has a max estimate of 44.21 CNY and a min estimate of 38.00 CNY. Watch 688166 chart and read a more detailed BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock forecast: see what analysts think of BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. and suggest that you do with its stocks.
688166 reached its all-time high on Jul 14, 2020 with the price of 72.43 CNY, and its all-time low was 17.10 CNY and was reached on Oct 12, 2022. View more price dynamics on 688166 chart.
See other stocks reaching their highest and lowest prices.
688166 stock is 3.77% volatile and has beta coefficient of 1.83. Track BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. there?
Today BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. has the market capitalization of ‪13.36 B‬, it has increased by 19.53% over the last week.
Yes, you can track BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. financials in yearly and quarterly reports right on TradingView.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. is going to release the next earnings report on Apr 14, 2025. Keep track of upcoming events with our Earnings Calendar.
688166 net income for the last quarter is ‪71.04 M‬ CNY, while the quarter before that showed ‪42.29 M‬ CNY of net income which accounts for 67.97% change. Track more BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. financial stats to get the full picture.
Yes, 688166 dividends are paid annually. The last dividend per share was 0.10 CNY. As of today, Dividend Yield (TTM)% is 0.30%. Tracking BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. dividends might help you take more informed decisions.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. dividend yield was 0.27% in 2023, and payout ratio reached 20.03%. The year before the numbers were 0.51% and 19.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪1.16 K‬ employees. See our rating of the largest employees — is BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. on this list?
Like other stocks, 688166 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock shows the buy signal. See more of BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.